Literature DB >> 10335856

Preimmunization epidemiology of hepatitis B virus infection in South African children.

E Vardas1, M Mathai, D Blaauw, J McAnerney, A Coppin, J Sim.   

Abstract

The prevalence of hepatitis B surface antigen (HBsAg) was determined in a community-based, cross-sectional, age-stratified sample of children from 0 to 6 years of age (n = 2,299) from the Eastern Cape Province of South Africa. The purpose of the study was to investigate the epidemiology and the age of acquisition of hepatitis B virus (HBV) infection in children, thus providing a preimmunization baseline measure of this infection in the population targeted for HBV immunization in South Africa. Overall, 10.4% (95% CI, 9.2-11.7) of the children tested were HBsAg-positive. There was a high rate of positivity in the 0-6- and 7-12-month age groups at 8.1% (95% CI, 5.5-11.7) and 8.9% (95% CI, 6.1-12.7), respectively, suggesting a higher rate of early acquisition of this infection than previously reported in South Africa. The proportion of HBsAg-positive children increased significantly with increasing age (chi2trend = 5.9, df = 1, P = 0.02), reaching 15.7% in the 61-72-month age group. This is the highest rate of HBV infection reported in community-based children from South Africa, indicating a significant burden of this infection. The difference in HBsAg prevalence between urban and rural children was not statistically significant (chi2 = 0.32, df = 1, P = 0.57). There was also no difference in positivity between males (10.5%; 95% CI, 8.7-12.5) and females (9.8%; 95% CI, 8.1-11.7), (chi2 = 0.006, df = 1, P = 0.94). This study provides the most recent preimmunization, community-based baseline investigation of the epidemiology of HBV infection in children targeted for universal immunization in South Africa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335856

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  19 in total

1.  Hepatitis B incidence and prevention with antiretroviral therapy among HIV-positive individuals in Uganda.

Authors:  Emmanuel Seremba; Victor Ssempijja; Sarah Kalibbala; Ronald H Gray; Maria J Wawer; Fred Nalugoda; Corey Casper; Warren Phipps; Ponsiano Ocama; David Serwadda; David L Thomas; Steven J Reynolds
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

Review 2.  HIV-HBV coinfection among South African patients receiving antiretroviral therapy.

Authors:  Adrian M Di Bisceglie; Mhairi Maskew; Doreen Schulze; Anne Reyneke; Lynne McNamara; Cindy Firnhaber
Journal:  Antivir Ther       Date:  2010

3.  Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants.

Authors:  Edina Amponsah-Dacosta; Ramokone L Lebelo; J Nare Rakgole; Selokela G Selabe; Maemu P Gededzha; Simnikiwe H Mayaphi; Eleanor A Powell; Jason T Blackard; M Jeffrey Mphahlele
Journal:  J Clin Virol       Date:  2014-12-03       Impact factor: 3.168

4.  Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants.

Authors:  Charles S Chasela; Athena P Kourtis; Patrick Wall; Jan Drobeniuc; Caroline C King; Hong Thai; Eyasu H Teshale; Mina Hosseinipour; Sascha Ellington; Mary B Codd; Denise J Jamieson; Rod Knight; Patricia Fitzpatrick; Saleem Kamili; Irving Hoffman; Dumbani Kayira; Noel Mumba; Deborah D Kamwendo; Francis Martinson; William Powderly; Chong-Gee Teo; Charles van der Horst
Journal:  J Hepatol       Date:  2013-11-06       Impact factor: 25.083

Review 5.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

Review 6.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  A high-efficiency superhydrophobic plasma separator.

Authors:  Changchun Liu; Shih-Chuan Liao; Jinzhao Song; Michael G Mauk; Xuanwen Li; Gaoxiang Wu; Dengteng Ge; Robert M Greenberg; Shu Yang; Haim H Bau
Journal:  Lab Chip       Date:  2016-02-07       Impact factor: 6.799

8.  Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa.

Authors:  C J Hoffmann; D Dayal; M Cheyip; J A McIntyre; G E Gray; S Conway; N A Martinson
Journal:  Int J STD AIDS       Date:  2012-10       Impact factor: 1.359

9.  Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.

Authors:  Trevor G Bell; Euphodia Makondo; Neil A Martinson; Anna Kramvis
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.

Authors:  John Rusine; Pascale Ondoa; Brenda Asiimwe-Kateera; Kimberly R Boer; Jean Marie Uwimana; Odette Mukabayire; Hans Zaaijer; Julie Mugabekazi; Peter Reiss; Janneke H van de Wijgert
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.